Dynamic Technology Lab Private Ltd - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 146 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.

Quarter-by-quarter ownership
Dynamic Technology Lab Private Ltd ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2023$735
+293.0%
54,751
+261.1%
0.07%
+257.9%
Q4 2022$187
-99.9%
15,163
+208.3%
0.02%
-68.3%
Q1 2020$310,000
+30.8%
4,918
+108.5%
0.06%
+46.3%
Q4 2018$237,000
-71.2%
2,359
-65.3%
0.04%
-73.7%
Q2 2017$824,000
+99.0%
6,798
+85.6%
0.16%
+60.8%
Q1 2017$414,0003,6620.10%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q4 2022
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders